lithium carbonate ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4207 554-13-2

Description:

MoleculeDescription

Synonyms:

  • lithium carbonate
  • carbonic acid, dilithium salt
  • dilithium carbonate
A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems.
  • Molecular weight: 73.89
  • Formula: CLi2O3
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 63.19
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
24 mmol O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 3 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 13 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 95 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 116.00 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD

Approvals:

DateAgencyCompanyOrphan
April 6, 1970 FDA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxicity to various agents 1443.44 12.99 1358 49346 223206 56018157
Tremor 766.85 12.99 728 49976 120361 56121002
Antipsychotic drug level increased 747.22 12.99 223 50481 3019 56238344
Neuroleptic malignant syndrome 677.97 12.99 287 50417 11191 56230172
Nephrogenic diabetes insipidus 649.81 12.99 153 50551 747 56240616
Drug interaction 586.97 12.99 827 49877 208928 56032435
Mania 540.54 12.99 245 50459 11275 56230088
Extrapyramidal disorder 478.15 12.99 230 50474 12126 56229237
Drug abuse 366.70 12.99 374 50330 67236 56174127
Hypomania 348.51 12.99 140 50564 4762 56236601
Agitation 331.49 12.99 325 50379 55711 56185652
Sopor 327.62 12.99 215 50489 20707 56220656
Psychotic disorder 318.47 12.99 221 50483 23337 56218026
Antipsychotic drug level above therapeutic 293.33 12.99 83 50621 918 56240445
Hyperparathyroidism 289.48 12.99 103 50601 2489 56238874
Bipolar disorder 280.86 12.99 137 50567 7443 56233920
Rheumatoid arthritis 280.58 12.99 16 50688 382588 55858775
Completed suicide 277.71 12.99 460 50244 133373 56107990
Confusional state 273.16 12.99 588 50116 207567 56033796
Ataxia 270.36 12.99 166 50538 14237 56227126
Intentional self-injury 268.48 12.99 204 50500 24788 56216575
Schizophrenia 265.97 12.99 147 50557 10352 56231011
Tardive dyskinesia 264.55 12.99 134 50570 7897 56233466
Suicidal ideation 262.64 12.99 291 50413 57451 56183912
Sedation 259.82 12.99 230 50474 34624 56206739
Pain 236.55 12.99 154 50550 663030 55578333
Suicide attempt 218.61 12.99 265 50439 57571 56183792
Parkinsonism 212.98 12.99 123 50581 9423 56231940
Dysarthria 207.43 12.99 215 50489 39335 56202028
Akathisia 199.76 12.99 114 50590 8538 56232825
Hypernatraemia 199.38 12.99 104 50600 6516 56234847
Overdose 197.29 12.99 347 50357 105483 56135880
Serotonin syndrome 189.85 12.99 171 50533 26319 56215044
Muscle rigidity 185.13 12.99 117 50587 10554 56230809
Catatonia 184.92 12.99 84 50620 3880 56237483
Salivary hypersecretion 176.61 12.99 98 50606 6952 56234411
Somnolence 174.68 12.99 426 50278 162987 56078376
Disorientation 172.45 12.99 188 50516 36425 56204938
Aggression 167.52 12.99 147 50557 21859 56219504
Arthralgia 167.30 12.99 125 50579 501544 55739819
Drug level increased 162.91 12.99 141 50563 20584 56220779
Pleurothotonus 160.90 12.99 56 50648 1265 56240098
Myoclonus 160.83 12.99 123 50581 15080 56226283
Delusion 160.47 12.99 109 50595 11106 56230257
Diabetes insipidus 154.08 12.99 64 50640 2373 56238990
Infusion related reaction 146.27 12.99 11 50693 208920 56032443
Dyspnoea 145.58 12.99 193 50511 592384 55648979
Intentional overdose 144.94 12.99 237 50467 67880 56173483
Systemic lupus erythematosus 143.64 12.99 4 50700 180074 56061289
Disturbance in attention 137.65 12.99 158 50546 32382 56208981
Delirium 137.06 12.99 180 50524 42337 56199026
Altered state of consciousness 135.04 12.99 133 50571 22888 56218475
Polyuria 134.01 12.99 84 50620 7467 56233896
Joint swelling 132.20 12.99 48 50656 289752 55951611
Electrocardiogram QT prolonged 131.41 12.99 201 50503 54387 56186976
Swelling 127.09 12.99 30 50674 239741 56001622
Contraindicated product administered 127.06 12.99 11 50693 186275 56055088
Arthropathy 125.90 12.99 16 50688 200259 56041104
Hallucination, auditory 125.78 12.99 95 50609 11429 56229934
Glossodynia 119.36 12.99 4 50700 152454 56088909
Jaundice cholestatic 117.51 12.99 69 50635 5450 56235913
Hypersensitivity 116.02 12.99 43 50661 256365 55984998
Nasopharyngitis 112.54 12.99 30 50674 220929 56020434
Alopecia 111.38 12.99 63 50641 293395 55947968
Restlessness 108.93 12.99 127 50577 26459 56214904
Irritability 107.56 12.99 133 50571 29455 56211908
Depression 106.13 12.99 380 50324 179737 56061626
Mental status changes 106.04 12.99 149 50555 37352 56204011
Abdominal discomfort 104.54 12.99 60 50644 277214 55964149
Abnormal behaviour 102.30 12.99 108 50596 20164 56221199
Dyskinesia 99.69 12.99 127 50577 28981 56212382
Polydipsia 97.92 12.99 51 50653 3184 56238179
Camptocormia 97.51 12.99 27 50677 274 56241089
Speech disorder 97.27 12.99 143 50561 37350 56204013
Hypothyroidism 96.68 12.99 144 50560 38052 56203311
Fatigue 96.23 12.99 376 50328 788176 55453187
Drug intolerance 96.04 12.99 60 50644 264758 55976605
Sinusitis 94.77 12.99 30 50674 197551 56043812
Obsessive-compulsive disorder 91.41 12.99 51 50653 3655 56237708
Granulocytopenia 91.20 12.99 58 50646 5286 56236077
Encephalopathy 90.59 12.99 134 50570 35191 56206172
Neurotoxicity 90.30 12.99 90 50614 15705 56225658
Coma 90.29 12.99 179 50525 59476 56181887
Hyperreflexia 89.65 12.99 57 50647 5193 56236170
Peripheral swelling 86.74 12.99 52 50652 234674 56006689
Postural tremor 85.24 12.99 23 50681 210 56241153
Mental disorder 84.03 12.99 105 50599 23499 56217864
Weight increased 84.01 12.99 419 50285 229284 56012079
Depressed level of consciousness 83.80 12.99 168 50536 56265 56185098
Bradyphrenia 82.22 12.99 59 50645 6561 56234802
Treatment failure 81.48 12.99 26 50678 170366 56070997
Poisoning 80.72 12.99 77 50627 12736 56228627
Pyramidal tract syndrome 79.96 12.99 24 50680 331 56241032
Hypercalcaemia 79.43 12.99 106 50598 25305 56216058
Depressed mood 77.96 12.99 127 50577 36232 56205131
Pruritus 77.62 12.99 103 50601 316520 55924843
Dystonia 77.03 12.99 74 50630 12347 56229016
Body tinea 75.55 12.99 33 50671 1387 56239976
Stomatitis 75.04 12.99 10 50694 120800 56120563
Bipolar I disorder 73.14 12.99 34 50670 1656 56239707
Rash 72.93 12.99 216 50488 492831 55748532
Libido increased 71.47 12.99 31 50673 1281 56240082
Psychomotor hyperactivity 69.56 12.99 63 50641 9757 56231606
Mutism 68.84 12.99 31 50673 1402 56239961
Apathy 68.40 12.99 57 50647 7897 56233466
Inhibitory drug interaction 68.23 12.99 36 50668 2308 56239055
Anaemia 67.63 12.99 85 50619 267426 55973937
Acute kidney injury 67.08 12.99 408 50296 240355 56001008
Blood prolactin increased 66.87 12.99 40 50664 3269 56238094
Antipsychotic drug level below therapeutic 66.83 12.99 20 50684 273 56241090
Cough 66.34 12.99 82 50622 259879 55981484
Aphasia 66.24 12.99 107 50597 30308 56211055
Electroencephalogram abnormal 64.38 12.99 40 50664 3499 56237864
Pain in extremity 63.88 12.99 106 50598 297325 55944038
Infection 63.83 12.99 52 50652 200154 56041209
Back pain 63.52 12.99 72 50632 237098 56004265
Schizoaffective disorder 63.13 12.99 37 50667 2912 56238451
Nephropathy 62.90 12.99 47 50657 5562 56235801
Grandiosity 62.27 12.99 19 50685 278 56241085
Parathyroid tumour benign 61.99 12.99 23 50681 628 56240735
Drug reaction with eosinophilia and systemic symptoms 61.14 12.99 103 50601 30201 56211162
Cogwheel rigidity 60.87 12.99 31 50673 1846 56239517
Therapeutic product effect decreased 60.54 12.99 39 50665 169413 56071950
Cerebellar syndrome 60.09 12.99 38 50666 3429 56237934
Psychiatric symptom 59.76 12.99 43 50661 4801 56236562
Logorrhoea 59.74 12.99 33 50671 2319 56239044
Glucose tolerance impaired 59.22 12.99 45 50659 5460 56235903
Paranoia 59.18 12.99 60 50644 10684 56230679
Brugada syndrome 58.77 12.99 19 50685 339 56241024
Disease progression 58.01 12.99 12 50692 105161 56136202
Poisoning deliberate 57.42 12.99 57 50647 9896 56231467
Stupor 57.35 12.99 39 50665 3979 56237384
Anticholinergic syndrome 57.14 12.99 30 50674 1904 56239459
Cognitive disorder 56.58 12.99 132 50572 49001 56192362
Febrile neutropenia 56.27 12.99 13 50691 105532 56135831
Tachyphrenia 56.09 12.99 26 50678 1258 56240105
Galactorrhoea 56.05 12.99 38 50666 3857 56237506
Gestational diabetes 55.68 12.99 51 50653 8013 56233350
Treatment noncompliance 55.63 12.99 103 50601 32520 56208843
Anxiety 55.46 12.99 330 50374 192842 56048521
Leukocytosis 54.98 12.99 86 50618 23705 56217658
Infection susceptibility increased 54.57 12.99 33 50671 2750 56238613
Death 54.54 12.99 144 50560 341282 55900081
Malignant neoplasm progression 54.04 12.99 3 50701 73584 56167779
Electrocardiogram T wave abnormal 52.44 12.99 30 50674 2256 56239107
Impaired healing 52.03 12.99 8 50696 86833 56154530
White blood cell count increased 51.27 12.99 120 50584 44639 56196724
Gastrointestinal disorder 50.74 12.99 19 50685 112683 56128680
Withdrawal syndrome 50.18 12.99 72 50632 18390 56222973
Hostility 50.14 12.99 27 50677 1804 56239559
Discomfort 50.13 12.99 33 50671 141728 56099635
Euphoric mood 49.94 12.99 37 50667 4321 56237042
Blister 49.62 12.99 18 50686 108869 56132494
Chronic kidney disease 49.54 12.99 114 50590 41942 56199421
Enuresis 49.34 12.99 29 50675 2294 56239069
Resting tremor 49.07 12.99 20 50684 706 56240657
Psychiatric decompensation 49.01 12.99 24 50680 1314 56240049
Blood creatine phosphokinase increased 48.60 12.99 89 50615 27863 56213500
Bradykinesia 48.55 12.99 38 50666 4816 56236547
Atrial fibrillation 47.96 12.99 19 50685 108878 56132485
Behaviour disorder 47.68 12.99 30 50674 2683 56238680
Headache 47.55 12.99 302 50402 558742 55682621
Mental impairment 47.54 12.99 58 50646 12664 56228699
Personality disorder 46.42 12.99 38 50666 5135 56236228
Drooling 45.37 12.99 32 50672 3462 56237901
Action tremor 45.23 12.99 15 50689 291 56241072
Product use issue 45.04 12.99 61 50643 185980 56055383
Neutrophil count increased 44.59 12.99 61 50643 14904 56226459
Cardio-respiratory arrest 43.60 12.99 129 50575 55192 56186171
Urticaria 43.15 12.99 40 50664 144636 56096727
Hallucination 42.99 12.99 119 50585 49030 56192333
Intentional product use issue 42.95 12.99 18 50686 99715 56141648
Bundle branch block right 42.87 12.99 35 50669 4712 56236651
Renal cyst 42.41 12.99 47 50657 9262 56232101
Substance abuse 42.21 12.99 34 50670 4491 56236872
Anger 41.66 12.99 52 50652 11620 56229743
Arthritis 41.45 12.99 19 50685 99833 56141530
Gastrointestinal haemorrhage 41.19 12.99 9 50695 75942 56165421
Psychomotor skills impaired 41.00 12.99 25 50679 2115 56239248
Sleep-related eating disorder 40.56 12.99 18 50686 786 56240577
Oculogyric crisis 40.41 12.99 22 50682 1502 56239861
Parkinsonian gait 39.48 12.99 15 50689 438 56240925
Asterixis 39.43 12.99 20 50684 1181 56240182
Soft tissue injury 39.42 12.99 22 50682 1577 56239786
Persecutory delusion 39.21 12.99 26 50678 2544 56238819
Cardiac failure congestive 39.13 12.99 15 50689 87705 56153658
Cholelithiasis 39.02 12.99 100 50604 39364 56201999
Hypothermia 38.94 12.99 52 50652 12418 56228945
Lower respiratory tract infection 38.88 12.99 28 50676 114766 56126597
Hypertonia 38.71 12.99 31 50673 4061 56237302
Lethargy 38.69 12.99 118 50586 51323 56190040
Poor quality sleep 38.02 12.99 62 50642 17693 56223670
Psoriatic arthropathy 37.72 12.99 10 50694 73998 56167365
Hyperprolactinaemia 37.35 12.99 29 50675 3632 56237731
Bronchitis 37.25 12.99 28 50676 112283 56129080
Urinary incontinence 36.85 12.99 82 50622 29503 56211860
Diarrhoea 36.37 12.99 384 50320 638123 55603240
Urinary retention 36.31 12.99 79 50625 27995 56213368
Goitre 36.07 12.99 34 50670 5539 56235824
Abdominal pain upper 36.00 12.99 66 50638 178247 56063116
Protein C increased 35.47 12.99 10 50694 109 56241254
Electrocardiogram T wave inversion 35.24 12.99 27 50677 3316 56238047
Hepatotoxicity 35.10 12.99 83 50621 31070 56210293
Mobility decreased 35.04 12.99 23 50681 98968 56142395
Thinking abnormal 35.02 12.99 44 50660 9897 56231466
Injection site erythema 34.95 12.99 13 50691 77435 56163928
Miosis 34.83 12.99 36 50668 6556 56234807
Interstitial lung disease 34.77 12.99 5 50699 57058 56184305
Visuospatial deficit 34.76 12.99 7 50697 13 56241350
Hallucination, visual 34.73 12.99 59 50645 17409 56223954
Choreoathetosis 34.70 12.99 14 50690 481 56240882
Chest pain 34.25 12.99 75 50629 189722 56051641
Haemodialysis 33.46 12.99 40 50664 8551 56232812
Blood sodium increased 32.80 12.99 23 50681 2465 56238898
Post-traumatic neck syndrome 32.59 12.99 21 50683 1957 56239406
Impulsive behaviour 32.50 12.99 19 50685 1488 56239875
Myocarditis 32.47 12.99 40 50664 8818 56232545
Blood bilirubin increased 32.44 12.99 84 50620 33270 56208093
Major depression 32.35 12.99 37 50667 7547 56233816
Impaired self-care 32.12 12.99 20 50684 1756 56239607
Insomnia 32.04 12.99 288 50416 191572 56049791
Hyperlipidaemia 31.91 12.99 58 50646 18051 56223312
Sternal fracture 31.54 12.99 21 50683 2069 56239294
Asthma 31.52 12.99 33 50671 112737 56128626
Renal oncocytoma 31.48 12.99 7 50697 25 56241338
Drug withdrawal syndrome 31.45 12.99 71 50633 25786 56215577
Gait disturbance 31.40 12.99 253 50451 163068 56078295
International normalised ratio abnormal 31.21 12.99 24 50680 2964 56238399
Neuropathy peripheral 31.21 12.99 28 50676 102865 56138498
Muscle twitching 31.17 12.99 54 50650 16188 56225175
Osteoarthritis 30.74 12.99 17 50687 80279 56161084
Respiratory arrest 30.69 12.99 78 50626 30547 56210816
Hallucinations, mixed 30.58 12.99 28 50676 4396 56236967
Pneumonia 30.54 12.99 228 50476 406870 55834493
Fibromyalgia 30.48 12.99 8 50696 59595 56181768
Hyperthyroidism 30.48 12.99 48 50656 13304 56228059
Rhabdomyolysis 30.33 12.99 93 50611 40565 56200798
Electrocardiogram abnormal 30.22 12.99 37 50667 8107 56233256
Cerebellar atrophy 30.07 12.99 14 50690 684 56240679
Mood swings 29.97 12.99 54 50650 16693 56224670
Hereditary ataxia 29.92 12.99 7 50697 33 56241330
Drug hypersensitivity 29.77 12.99 137 50567 275068 55966295
Clonus 29.58 12.99 27 50677 4222 56237141
Pressure of speech 29.50 12.99 13 50691 558 56240805
Schizoaffective disorder bipolar type 29.05 12.99 9 50695 139 56241224
Impaired quality of life 29.04 12.99 37 50667 8437 56232926
Drug level above therapeutic 28.98 12.99 27 50677 4335 56237028
Papillary thyroid cancer 28.86 12.99 20 50684 2104 56239259
Musculoskeletal pain 28.53 12.99 19 50685 81133 56160230
Induced abortion failed 28.52 12.99 10 50694 231 56241132
Sinus bradycardia 28.50 12.99 47 50657 13539 56227824
Electric shock sensation 27.91 12.99 12 50692 485 56240878
Social avoidant behaviour 27.82 12.99 22 50682 2830 56238533
Depressive symptom 27.63 12.99 24 50680 3517 56237846
Adams-Stokes syndrome 27.34 12.99 7 50697 51 56241312
Acute psychosis 27.33 12.99 20 50684 2292 56239071
Deprescribing error 27.07 12.99 6 50698 21 56241342
Persistent depressive disorder 26.76 12.99 14 50690 882 56240481
Knee arthroplasty 26.68 12.99 4 50700 44255 56197108
Platelet count decreased 26.63 12.99 34 50670 106349 56135014
International normalised ratio increased 26.51 12.99 4 50700 44037 56197326
Differential white blood cell count abnormal 26.42 12.99 13 50691 719 56240644
Mood altered 26.41 12.99 45 50659 13310 56228053
Plasma cell myeloma 26.39 12.99 5 50699 46641 56194722
Injection site swelling 26.13 12.99 4 50700 43574 56197789
Hyperthermia malignant 26.10 12.99 13 50691 738 56240625
Nodal rhythm 26.10 12.99 17 50687 1614 56239749
Ileus paralytic 26.02 12.99 25 50679 4170 56237193
Reflexes abnormal 25.88 12.99 12 50692 581 56240782
Maternal exposure during pregnancy 25.83 12.99 86 50618 189467 56051896
Cerebrovascular accident 25.61 12.99 31 50673 99239 56142124
Abdominal pain 25.58 12.99 133 50571 258672 55982691
Sepsis 25.43 12.99 55 50649 139785 56101578
Affect lability 25.36 12.99 38 50666 10087 56231276
Hypotonia 25.30 12.99 35 50669 8642 56232721
Thrombocytopenia 25.26 12.99 53 50651 136171 56105192
Hypokinesia 25.13 12.99 43 50661 12760 56228603
Increased appetite 25.12 12.99 35 50669 8700 56232663
Eye movement disorder 25.02 12.99 26 50678 4763 56236600
Thyrotoxic crisis 24.86 12.99 13 50691 818 56240545
Muscle contractions involuntary 24.83 12.99 18 50686 2033 56239330
Purpura 24.69 12.99 38 50666 10324 56231039
COVID-19 24.51 12.99 19 50685 75039 56166324
Myocarditis septic 24.44 12.99 6 50698 36 56241327
Nystagmus 24.14 12.99 28 50676 5797 56235566
Irritable bowel syndrome 24.10 12.99 16 50688 68442 56172921
Paraesthesia 24.01 12.99 51 50653 130463 56110900
Injection site pain 23.94 12.99 43 50661 117075 56124288
Bruxism 23.78 12.99 21 50683 3145 56238218
Sluggishness 23.78 12.99 25 50679 4643 56236720
Antidepressant drug level increased 23.65 12.99 9 50695 264 56241099
Conversion disorder 23.62 12.99 16 50688 1622 56239741
Ammonia increased 23.52 12.99 24 50680 4305 56237058
Lung disorder 23.44 12.99 9 50695 52588 56188775
Cerebral atrophy 23.37 12.99 25 50679 4735 56236628
Affective disorder 23.33 12.99 27 50677 5576 56235787
Feeling guilty 23.28 12.99 11 50693 556 56240807
Ideas of reference 22.90 12.99 7 50697 103 56241260
Pleural effusion 22.79 12.99 26 50678 85454 56155909
General physical health deterioration 22.57 12.99 78 50626 169932 56071431
Encopresis 22.42 12.99 7 50697 111 56241252
Histrionic personality disorder 22.31 12.99 6 50698 54 56241309
Poverty of speech 22.23 12.99 9 50695 312 56241051
Nausea 21.94 12.99 523 50181 763655 55477708
Compulsive sexual behaviour 21.93 12.99 6 50698 58 56241305
Coordination abnormal 21.70 12.99 40 50664 12581 56228782
Electroconvulsive therapy 21.66 12.99 6 50698 61 56241302
Ill-defined disorder 21.57 12.99 18 50686 68525 56172838
Mucosal inflammation 21.41 12.99 6 50698 42804 56198559
Drug level decreased 21.36 12.99 29 50675 7035 56234328
Nephropathy toxic 21.35 12.99 32 50672 8495 56232868
Oscillopsia 21.29 12.99 7 50697 132 56241231
Status epilepticus 21.19 12.99 44 50660 15097 56226266
Language disorder 21.17 12.99 16 50688 1925 56239438
Blunted affect 21.04 12.99 8 50696 234 56241129
Dialysis 20.94 12.99 34 50670 9668 56231695
Borderline personality disorder 20.66 12.99 11 50693 718 56240645
Medication error 20.49 12.99 84 50620 42251 56199112
Anaphylactic reaction 20.48 12.99 14 50690 58981 56182382
Drug ineffective 20.45 12.99 652 50052 918337 55323026
Megacolon 20.37 12.99 15 50689 1736 56239627
Long QT syndrome 20.36 12.99 19 50685 3057 56238306
Limbic encephalitis 20.28 12.99 8 50696 259 56241104
Hyporeflexia 20.21 12.99 15 50689 1756 56239607
Mydriasis 20.19 12.99 36 50668 11035 56230328
Bone pain 20.13 12.99 10 50694 50175 56191188
Water intoxication 19.76 12.99 9 50695 418 56240945
Lactate pyruvate ratio increased 19.53 12.99 6 50698 90 56241273
Disinhibition 19.44 12.99 11 50693 810 56240553
Hyperammonaemia 19.24 12.99 23 50681 4917 56236446
Hyperthermia 19.21 12.99 30 50674 8255 56233108
Rhinorrhoea 19.19 12.99 14 50690 57023 56184340
Delusion of reference 19.00 12.99 6 50698 99 56241264
Neuropsychiatric symptoms 18.95 12.99 10 50694 641 56240722
Flat affect 18.92 12.99 13 50691 1349 56240014
Memory impairment 18.80 12.99 138 50566 86419 56154944
Lipids decreased 18.78 12.99 4 50700 11 56241352
Irregular sleep wake rhythm disorder 18.77 12.99 7 50697 194 56241169
Tachycardia 18.72 12.99 161 50543 105715 56135648
Arachnoid cyst 18.70 12.99 7 50697 196 56241167
Productive cough 18.66 12.99 14 50690 56218 56185145
Refusal of treatment by patient 18.51 12.99 23 50681 5115 56236248
Self-injurious ideation 18.48 12.99 16 50688 2334 56239029
Ear infection 18.47 12.99 3 50701 31292 56210071
Homicidal ideation 18.46 12.99 14 50690 1694 56239669
Renal impairment 18.29 12.99 130 50574 80583 56160780
Merycism 18.28 12.99 7 50697 209 56241154
Skin ulcer 18.24 12.99 6 50698 38602 56202761
Acquired cystic kidney disease 18.21 12.99 5 50699 49 56241314
Agranulocytosis 18.00 12.99 53 50651 22606 56218757
Somatic symptom disorder 17.98 12.99 15 50689 2080 56239283
Dysphoria 17.97 12.99 22 50682 4820 56236543
Urine osmolarity increased 17.92 12.99 6 50698 120 56241243
Unresponsive to stimuli 17.84 12.99 66 50638 31659 56209704
Cardiac failure 17.82 12.99 29 50675 82064 56159299
Staring 17.80 12.99 13 50691 1485 56239878
Impaired work ability 17.71 12.99 40 50664 14532 56226831
Influenza 17.71 12.99 37 50667 95224 56146139
Dyspnoea exertional 17.66 12.99 14 50690 54675 56186688
Psychomotor retardation 17.54 12.99 19 50685 3650 56237713
Haemorrhage 17.51 12.99 15 50689 56382 56184981
Seizure 17.50 12.99 181 50523 124938 56116425
Psychotic disorder due to a general medical condition 17.48 12.99 7 50697 236 56241127
Throat irritation 17.46 12.99 4 50700 32679 56208684
Toxic encephalopathy 17.38 12.99 24 50680 5914 56235449
Blood citric acid increased 17.37 12.99 5 50699 59 56241304
Hallucination, olfactory 17.31 12.99 7 50697 242 56241121
Clear cell renal cell carcinoma 17.30 12.99 12 50692 1264 56240099
Essential tremor 17.20 12.99 11 50693 1012 56240351
Balance disorder 17.19 12.99 123 50581 76397 56164966
Negativism 17.11 12.99 8 50696 395 56240968
Antidepressant drug level above therapeutic 16.92 12.99 8 50696 405 56240958
Slow speech 16.88 12.99 12 50692 1315 56240048
Cardiac arrest 16.73 12.99 134 50570 86180 56155183
Pneumonitis 16.59 12.99 4 50700 31560 56209803
Alcohol interaction 16.59 12.99 15 50689 2318 56239045
Blood urea increased 16.44 12.99 54 50650 24419 56216944
Psoriasis 16.40 12.99 37 50667 92655 56148708
Compartment syndrome 16.36 12.99 14 50690 2010 56239353
Neurological symptom 16.25 12.99 21 50683 4855 56236508
Hypotonia neonatal 16.25 12.99 11 50693 1113 56240250
Thyroiditis 16.20 12.99 14 50690 2038 56239325
Epileptic encephalopathy 16.17 12.99 7 50697 288 56241075
Colectomy total 16.13 12.99 6 50698 165 56241198
Retroperitoneal fibrosis 16.07 12.99 7 50697 292 56241071
Hyperhidrosis 16.07 12.99 142 50562 93946 56147417
Pain in jaw 16.02 12.99 8 50696 40028 56201335
Osteoporosis 15.98 12.99 14 50690 52038 56189325
Acalculia 15.96 12.99 3 50701 3 56241360
Potentiating drug interaction 15.95 12.99 19 50685 4047 56237316
Ascites 15.80 12.99 7 50697 37537 56203826
Antipsychotic drug level decreased 15.75 12.99 7 50697 307 56241056
Echolalia 15.73 12.99 6 50698 177 56241186
Tonsillar hypertrophy 15.72 12.99 10 50694 912 56240451
Urine output increased 15.58 12.99 11 50693 1192 56240171
Inflammation 15.37 12.99 24 50680 69047 56172316
Malaise 15.35 12.99 236 50468 367624 55873739
Slow response to stimuli 15.31 12.99 10 50694 954 56240409
Cystitis 15.28 12.99 13 50691 49025 56192338
Breast engorgement 15.17 12.99 5 50699 95 56241268
Foetal malnutrition 15.12 12.99 5 50699 96 56241267
Neonatal respiratory distress 15.11 12.99 7 50697 338 56241025
Muscle spasms 15.06 12.99 68 50636 137303 56104060
Thought blocking 14.98 12.99 5 50699 99 56241264
Haemoglobin decreased 14.94 12.99 66 50638 134071 56107292
Blood pressure fluctuation 14.80 12.99 9 50695 40351 56201012
Upper respiratory tract infection 14.72 12.99 26 50678 71262 56170101
Ileus 14.58 12.99 36 50668 13846 56227517
Off label use 14.47 12.99 386 50318 555794 55685569
Gaze palsy 14.41 12.99 11 50693 1344 56240019
Injection site reaction 14.41 12.99 16 50688 53231 56188132
Delusional perception 14.40 12.99 6 50698 224 56241139
Movement disorder 14.39 12.99 44 50660 19154 56222209
Suspected suicide 14.39 12.99 21 50683 5445 56235918
Osteonecrosis of jaw 14.39 12.99 6 50698 33352 56208011
Bone density decreased 14.38 12.99 34 50670 12726 56228637
Cardiomyopathy acute 14.33 12.99 6 50698 227 56241136
Stevens-Johnson syndrome 14.33 12.99 49 50655 22614 56218749
Distal intestinal obstruction syndrome 14.26 12.99 7 50697 385 56240978
Sexually inappropriate behaviour 14.16 12.99 5 50699 118 56241245
Glomerulonephritis minimal lesion 14.09 12.99 6 50698 237 56241126
Melaena 14.08 12.99 4 50700 28286 56213077
Femur fracture 14.08 12.99 9 50695 39286 56202077
Wheezing 14.06 12.99 29 50675 74997 56166366
Dysphemia 14.03 12.99 14 50690 2446 56238917
Decreased activity 14.01 12.99 21 50683 5575 56235788
Joint injury 13.99 12.99 3 50701 25651 56215712
Loss of personal independence in daily activities 13.98 12.99 33 50671 81336 56160027
Breast cancer 13.97 12.99 14 50690 48819 56192544
Tooth injury 13.90 12.99 10 50694 1116 56240247
Thought insertion 13.89 12.99 3 50701 9 56241354
Polyhydramnios 13.87 12.99 13 50691 2102 56239261
Muscle tone disorder 13.85 12.99 5 50699 126 56241237
Thrombosis 13.85 12.99 20 50684 59407 56181956
Progressive supranuclear palsy 13.84 12.99 4 50700 48 56241315
Stereotypy 13.77 12.99 7 50697 415 56240948
Blood pressure systolic increased 13.77 12.99 10 50694 40826 56200537
Joint range of motion decreased 13.76 12.99 3 50701 25362 56216001
Distractibility 13.68 12.99 7 50697 421 56240942
Amenorrhoea 13.63 12.99 27 50677 8959 56232404
Cerebellar ataxia 13.60 12.99 9 50695 878 56240485
Unmasking of previously unidentified disease 13.57 12.99 9 50695 881 56240482
Haematoma 13.43 12.99 6 50698 32013 56209350
Localised infection 13.42 12.99 4 50700 27408 56213955
Abulia 13.38 12.99 7 50697 441 56240922
Brain injury 13.35 12.99 22 50682 6333 56235030
Epistaxis 13.34 12.99 25 50679 66998 56174365
Amimia 13.34 12.99 4 50700 55 56241308
Food craving 13.30 12.99 11 50693 1508 56239855
Respiratory tract infection 13.28 12.99 8 50696 36063 56205300
Middle insomnia 13.24 12.99 30 50674 10920 56230443
Neutrophilia 13.21 12.99 17 50687 3916 56237447
Liver injury 13.15 12.99 11 50693 41837 56199526
Haematochezia 13.13 12.99 12 50692 43706 56197657
Hip fracture 13.08 12.99 4 50700 26969 56214394
Urinary tract infection 13.07 12.99 146 50558 240367 56000996
Dry eye 13.04 12.99 8 50696 35708 56205655
Nightmare 13.02 12.99 39 50665 16787 56224576
Blood pressure increased 13.01 12.99 77 50627 145099 56096264

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxicity to various agents 850.92 14.24 1073 37615 180414 31478242
Neuroleptic malignant syndrome 593.48 14.24 325 38363 16544 31642112
Antipsychotic drug level increased 557.13 14.24 195 38493 3263 31655393
Mania 547.66 14.24 253 38435 8924 31649732
Tremor 525.47 14.24 552 38136 75868 31582788
Nephrogenic diabetes insipidus 402.13 14.24 118 38570 1076 31657580
Akathisia 306.48 14.24 158 38530 7095 31651561
Suicide attempt 288.04 14.24 287 38401 36961 31621695
Extrapyramidal disorder 267.11 14.24 171 38517 11607 31647049
Obsessive-compulsive disorder 266.33 14.24 127 38561 4810 31653846
Parkinsonism 246.16 14.24 139 38549 7497 31651159
Antipsychotic drug level below therapeutic 240.16 14.24 91 38597 1924 31656732
Drug interaction 233.29 14.24 668 38020 207875 31450781
Bipolar disorder 204.54 14.24 97 38591 3627 31655029
Serotonin syndrome 199.94 14.24 173 38515 18600 31640056
Psychotic disorder 197.14 14.24 185 38503 22108 31636548
Antipsychotic drug level above therapeutic 184.28 14.24 65 38623 1112 31657544
Dysarthria 165.96 14.24 200 38488 31817 31626839
Disinhibition 159.80 14.24 74 38614 2619 31656037
Euphoric mood 159.75 14.24 90 38598 4830 31653826
Suicidal ideation 157.83 14.24 208 38480 36198 31622458
Agitation 155.79 14.24 255 38433 53914 31604742
Psychomotor hyperactivity 154.60 14.24 109 38579 8678 31649978
Therapeutic product effect variable 152.79 14.24 65 38623 1873 31656783
Granulocytopenia 151.91 14.24 94 38594 6005 31652651
Sedation 148.08 14.24 147 38541 18818 31639838
Hypomania 147.06 14.24 66 38622 2169 31656487
Increased appetite 146.02 14.24 93 38595 6251 31652405
Diabetes insipidus 145.14 14.24 68 38620 2472 31656184
Weight increased 139.85 14.24 311 38377 82636 31576020
Confusional state 135.18 14.24 413 38275 132921 31525735
Aggression 131.61 14.24 193 38495 37098 31621558
Ataxia 123.88 14.24 112 38576 12751 31645905
Dyspnoea 123.42 14.24 143 38545 343336 31315320
Irritability 121.90 14.24 145 38543 22744 31635912
Febrile neutropenia 117.60 14.24 8 38680 121841 31536815
Dyskinesia 113.89 14.24 134 38554 20776 31637880
Salivary hypersecretion 112.95 14.24 86 38602 7706 31650950
Schizophrenia 105.67 14.24 95 38593 10735 31647921
Delusion 103.03 14.24 98 38590 11899 31646757
Schizoaffective disorder 101.29 14.24 43 38645 1232 31657424
Completed suicide 100.72 14.24 292 38396 91222 31567434
Hallucination, auditory 99.35 14.24 90 38598 10270 31648386
Death 95.61 14.24 185 38503 360384 31298272
Myoclonus 93.92 14.24 100 38588 13890 31644766
Tardive dyskinesia 93.26 14.24 67 38621 5492 31653164
Hypernatraemia 90.54 14.24 75 38613 7588 31651068
Arthralgia 90.22 14.24 36 38652 151388 31507268
Muscle rigidity 89.11 14.24 83 38605 9814 31648842
Leukopenia 87.63 14.24 208 38480 57620 31601036
Bruxism 85.06 14.24 41 38647 1589 31657067
Anaemia 83.06 14.24 83 38605 213439 31445217
Priapism 82.86 14.24 58 38630 4562 31654094
Overdose 82.63 14.24 259 38429 84405 31574251
Hyperparathyroidism 81.33 14.24 36 38652 1144 31657512
Somnolence 78.29 14.24 283 38405 99162 31559494
White blood cell count increased 78.12 14.24 157 38531 38843 31619813
Cough 77.16 14.24 34 38654 134780 31523876
Catatonia 76.16 14.24 56 38632 4758 31653898
Sopor 74.77 14.24 81 38607 11471 31647185
Oppositional defiant disorder 74.01 14.24 27 38661 511 31658145
Delirium 73.89 14.24 159 38529 41262 31617394
Pain 72.14 14.24 73 38615 186686 31471970
Coordination abnormal 71.51 14.24 64 38624 7187 31651469
Decreased eye contact 68.98 14.24 25 38663 464 31658192
Intentional overdose 68.31 14.24 154 38534 41235 31617421
Abnormal behaviour 68.19 14.24 112 38576 23716 31634940
Disease progression 67.62 14.24 14 38674 90450 31568206
Pneumonia 65.91 14.24 201 38487 335111 31323545
Pain in extremity 65.39 14.24 30 38658 116173 31542483
Mental status changes 65.22 14.24 139 38549 35829 31622827
Homicidal ideation 64.68 14.24 40 38648 2551 31656105
Malignant neoplasm progression 63.86 14.24 10 38678 78988 31579668
Dyslipidaemia 62.10 14.24 56 38632 6350 31652306
Coma 61.21 14.24 147 38541 41003 31617653
Cognitive disorder 59.34 14.24 108 38580 24815 31633841
Blood creatine phosphokinase increased 59.30 14.24 147 38541 41827 31616829
Neutrophil count increased 59.23 14.24 84 38604 15647 31643009
Polydipsia 57.86 14.24 42 38646 3498 31655158
Hyperreflexia 57.55 14.24 39 38649 2910 31655746
Depressed level of consciousness 55.39 14.24 136 38552 38465 31620191
Restlessness 55.32 14.24 101 38587 23260 31635396
Obesity 55.29 14.24 68 38620 11032 31647624
Bipolar I disorder 53.43 14.24 24 38664 790 31657866
Dystonia 53.14 14.24 64 38624 10161 31648495
Brugada syndrome 53.04 14.24 23 38665 695 31657961
Depression 51.89 14.24 234 38454 90581 31568075
Affect lability 51.89 14.24 39 38649 3426 31655230
Prescribed overdose 51.85 14.24 60 38628 9132 31649524
Disturbance in attention 51.82 14.24 96 38592 22354 31636302
Atrial fibrillation 51.76 14.24 38 38650 113745 31544911
Pancytopenia 51.56 14.24 21 38667 87295 31571361
Interstitial lung disease 51.41 14.24 7 38681 61396 31597260
Disorientation 51.40 14.24 115 38573 30629 31628027
Back pain 50.47 14.24 36 38652 109377 31549279
Neurotoxicity 50.15 14.24 79 38609 16147 31642509
Treatment noncompliance 49.75 14.24 102 38586 25582 31633074
Speech disorder 49.13 14.24 98 38590 24103 31634553
Thinking abnormal 48.75 14.24 46 38642 5527 31653129
Fatigue 47.08 14.24 230 38458 334976 31323680
Pruritus 47.06 14.24 50 38638 125117 31533539
Myocarditis 46.96 14.24 65 38623 11835 31646821
Hypothyroidism 46.88 14.24 81 38607 17866 31640790
Dystonic tremor 46.66 14.24 15 38673 190 31658466
Rheumatoid arthritis 46.49 14.24 3 38685 47806 31610850
Anxiety 46.46 14.24 227 38461 90806 31567850
Peripheral swelling 45.82 14.24 13 38675 67852 31590804
Oedema peripheral 45.80 14.24 40 38648 109799 31548857
Thrombocytopenia 45.30 14.24 65 38623 142682 31515974
Electrocardiogram QRS complex prolonged 45.05 14.24 39 38649 4190 31654466
Plasma cell myeloma 43.81 14.24 8 38680 56523 31602133
Clonus 43.72 14.24 31 38657 2488 31656168
Paranoia 43.69 14.24 59 38629 10496 31648160
Delusion of grandeur 43.46 14.24 20 38668 697 31657959
General physical health deterioration 42.99 14.24 45 38643 113390 31545266
Cardiac failure congestive 42.35 14.24 22 38666 79365 31579291
Gastrointestinal haemorrhage 40.98 14.24 25 38663 82524 31576132
Sepsis 40.91 14.24 77 38611 151852 31506804
Affective disorder 40.90 14.24 35 38653 3701 31654955
Cerebellar syndrome 40.56 14.24 28 38660 2153 31656503
Failure to suspend medication 39.57 14.24 16 38672 404 31658252
Choreoathetosis 39.33 14.24 21 38667 1012 31657644
Rash 39.31 14.24 121 38567 201365 31457291
Infusion related reaction 39.01 14.24 6 38682 48049 31610607
Logorrhoea 39.01 14.24 28 38660 2291 31656365
Myocardial infarction 38.68 14.24 49 38639 113405 31545251
Intentional self-injury 38.64 14.24 63 38625 13252 31645404
Insomnia 37.82 14.24 221 38467 94615 31564041
Tachycardia foetal 37.77 14.24 15 38673 361 31658295
Electrocardiogram QT prolonged 37.73 14.24 117 38571 37870 31620786
Drug level above therapeutic 37.08 14.24 33 38655 3677 31654979
Hyperparathyroidism primary 37.04 14.24 12 38676 156 31658500
Blood thyroid stimulating hormone decreased 36.97 14.24 25 38663 1858 31656798
Nephropathy 34.72 14.24 38 38650 5441 31653215
Apathy 34.38 14.24 41 38647 6441 31652215
Balance disorder 34.19 14.24 112 38576 37310 31621346
Anger 34.05 14.24 54 38634 11099 31647557
Tachycardia 33.96 14.24 183 38505 76024 31582632
Leukocytosis 33.95 14.24 80 38608 22034 31636622
Enuresis 33.63 14.24 25 38663 2159 31656497
Psychiatric decompensation 33.56 14.24 24 38664 1952 31656704
Antipsychotic drug level decreased 33.40 14.24 18 38670 884 31657772
Drug level increased 33.16 14.24 75 38613 20111 31638545
Mental impairment 33.11 14.24 49 38639 9483 31649173
Joint swelling 32.94 14.24 12 38676 53419 31605237
Septic shock 32.88 14.24 20 38668 66138 31592518
Grandiosity 32.80 14.24 13 38675 311 31658345
Abulia 32.59 14.24 15 38673 523 31658133
Hyperkinesia 32.34 14.24 22 38666 1651 31657005
Hyperprolactinaemia 32.19 14.24 21 38667 1470 31657186
Distractibility 31.62 14.24 13 38675 343 31658313
Trismus 31.49 14.24 25 38663 2380 31656276
Polyuria 31.44 14.24 43 38645 7740 31650916
Pressure of speech 31.30 14.24 14 38674 456 31658200
Diarrhoea 31.10 14.24 278 38410 352131 31306525
Leukaemia 31.03 14.24 31 38657 3994 31654662
Blood prolactin increased 30.55 14.24 21 38667 1603 31657053
Patient restraint 30.28 14.24 9 38679 86 31658570
Prostate cancer 29.83 14.24 5 38683 37596 31621060
Mental disorder 29.25 14.24 57 38631 13777 31644879
Melaena 29.11 14.24 3 38685 32651 31626005
Coronary artery disease 29.01 14.24 10 38678 46077 31612579
Metabolic syndrome 28.91 14.24 20 38668 1543 31657113
Abdominal pain 28.90 14.24 87 38601 145865 31512791
Epistaxis 28.46 14.24 15 38673 53692 31604964
Decreased appetite 28.46 14.24 94 38594 153123 31505533
Sexually inappropriate behaviour 28.44 14.24 13 38675 446 31658210
Thrombosis 28.07 14.24 10 38678 45141 31613515
Sexual dysfunction 27.23 14.24 35 38653 5933 31652723
Acute myocardial infarction 27.22 14.24 14 38674 50809 31607847
Bradyphrenia 26.97 14.24 30 38658 4374 31654282
Eosinophil count decreased 26.47 14.24 17 38671 1158 31657498
Mucosal inflammation 26.39 14.24 5 38683 34422 31624234
Headache 26.28 14.24 125 38563 183527 31475129
Lethargy 26.24 14.24 105 38583 38536 31620120
Haemoptysis 26.17 14.24 4 38684 32185 31626471
Hyperthermia 25.92 14.24 45 38643 9959 31648697
Poisoning deliberate 25.86 14.24 38 38650 7306 31651350
Intentional product use issue 25.83 14.24 14 38674 49333 31609323
Restless legs syndrome 25.69 14.24 39 38649 7717 31650939
Blunted affect 25.59 14.24 11 38677 325 31658331
Cardiac failure 25.44 14.24 41 38647 85912 31572744
Infection 25.28 14.24 38 38650 81893 31576763
Therapeutic product effect incomplete 25.22 14.24 113 38575 43583 31615073
Flight of ideas 25.16 14.24 11 38677 339 31658317
Blood sodium increased 25.00 14.24 23 38665 2676 31655980
Cogwheel rigidity 24.91 14.24 17 38671 1283 31657373
Pleural effusion 24.85 14.24 33 38655 74887 31583769
Hypersensitivity 24.83 14.24 19 38669 55724 31602932
Metabolic encephalopathy 24.69 14.24 27 38661 3862 31654794
Neuropathy peripheral 24.41 14.24 34 38654 75615 31583041
Cerebrovascular accident 24.40 14.24 37 38651 79447 31579209
Major depression 24.39 14.24 28 38660 4225 31654431
Otospondylomegaepiphyseal dysplasia 24.35 14.24 8 38680 109 31658547
Crying 24.25 14.24 32 38656 5565 31653091
Electroconvulsive therapy 24.25 14.24 6 38682 26 31658630
Drooling 24.16 14.24 24 38664 3071 31655585
Muscle spasms 23.79 14.24 29 38659 68289 31590367
Schizoaffective disorder bipolar type 23.73 14.24 7 38681 65 31658591
Musculoskeletal pain 23.59 14.24 4 38684 29824 31628832
Productive cough 23.43 14.24 6 38682 33534 31625122
Blood triglycerides increased 23.38 14.24 51 38637 13346 31645310
Sleep disorder 23.30 14.24 78 38610 26270 31632386
Depressed mood 23.19 14.24 60 38628 17515 31641141
Persistent depressive disorder 23.09 14.24 10 38678 301 31658355
Cerebral haemorrhage 22.67 14.24 6 38682 32806 31625850
Encephalopathy 22.66 14.24 89 38599 32385 31626271
Haemorrhage 22.57 14.24 15 38673 47319 31611337
Agranulocytosis 22.55 14.24 67 38621 21180 31637476
Hypotonia neonatal 22.47 14.24 16 38672 1293 31657363
Pneumonitis 22.36 14.24 5 38683 30647 31628009
Hydrops foetalis 22.24 14.24 11 38677 451 31658205
Altered state of consciousness 21.98 14.24 66 38622 20985 31637671
Self-injurious ideation 21.87 14.24 17 38671 1570 31657086
Angioedema 21.67 14.24 7 38681 33611 31625045
Anaphylactic reaction 21.20 14.24 5 38683 29548 31629108
Arthritis 20.94 14.24 4 38684 27381 31631275
Diabetes mellitus 20.88 14.24 105 38583 42451 31616205
Feelings of worthlessness 20.84 14.24 9 38679 269 31658387
Hepatic failure 20.74 14.24 7 38681 32695 31625961
Urinary incontinence 20.69 14.24 57 38631 17263 31641393
Apraxia 20.64 14.24 15 38673 1251 31657405
Urticaria 20.47 14.24 24 38664 57493 31601163
Floppy infant 20.39 14.24 7 38681 110 31658546
Gait disturbance 20.36 14.24 163 38525 77332 31581324
Dyspnoea exertional 20.35 14.24 11 38677 38826 31619830
Memory impairment 20.08 14.24 96 38592 38034 31620622
Psychotic symptom 19.86 14.24 16 38672 1556 31657100
Erythema 19.70 14.24 43 38645 80362 31578294
Mood altered 19.64 14.24 36 38652 8310 31650346
Bone marrow failure 19.58 14.24 5 38683 28003 31630653
Renal cyst 19.43 14.24 36 38652 8380 31650276
Chest discomfort 19.35 14.24 19 38669 49350 31609306
Drug hypersensitivity 19.33 14.24 37 38651 72562 31586094
Bipolar II disorder 19.30 14.24 5 38683 27 31658629
Movement disorder 19.29 14.24 42 38646 10977 31647679
Stupor 18.85 14.24 20 38668 2764 31655892
Eosinophil count increased 18.84 14.24 34 38654 7757 31650899
Antipsychotic drug level 18.80 14.24 4 38684 7 31658649
Oncocytoma 18.80 14.24 4 38684 7 31658649
Staphylococcal infection 18.67 14.24 7 38681 30625 31628031
Upper gastrointestinal haemorrhage 18.57 14.24 3 38685 23180 31635476
Dysphemia 18.44 14.24 15 38673 1479 31657177
Wrong patient received product 18.43 14.24 19 38669 2540 31656116
Weight decreased 18.40 14.24 117 38571 159835 31498821
Herpes zoster 18.38 14.24 8 38680 31985 31626671
Impulsive behaviour 18.34 14.24 17 38671 1996 31656660
Convulsive threshold lowered 18.30 14.24 10 38678 505 31658151
Speech sound disorder 18.21 14.24 7 38681 154 31658502
Abdominal distension 18.20 14.24 21 38667 50663 31607993
International normalised ratio increased 18.20 14.24 17 38671 45206 31613450
Blood thyroid stimulating hormone increased 18.15 14.24 22 38666 3515 31655141
Differential white blood cell count abnormal 17.95 14.24 14 38674 1299 31657357
Poor quality sleep 17.92 14.24 33 38655 7645 31651011
Angina pectoris 17.69 14.24 7 38681 29634 31629022
Depressive symptom 17.63 14.24 17 38671 2097 31656559
Social anxiety disorder 17.60 14.24 8 38680 271 31658385
Kidney enlargement 17.53 14.24 11 38677 720 31657936
Gambling disorder 17.52 14.24 15 38673 1587 31657069
Muscle twitching 17.51 14.24 34 38654 8196 31650460
Haematoma 17.48 14.24 4 38684 24135 31634521
Cerebral infarction 17.48 14.24 5 38683 25972 31632684
Libido increased 17.46 14.24 11 38677 725 31657931
High-grade B-cell lymphoma 17.41 14.24 7 38681 174 31658482
Syncope 17.40 14.24 50 38638 85132 31573524
Secondary tic 17.31 14.24 4 38684 12 31658644
Autonomic nervous system imbalance 17.20 14.24 18 38670 2449 31656207
Hallucination 17.10 14.24 106 38582 46304 31612352
Nephrolithiasis 17.08 14.24 6 38682 27333 31631323
Hallucination, olfactory 17.05 14.24 7 38681 184 31658472
Accidental death 16.95 14.24 17 38671 2200 31656456
Stomatitis 16.86 14.24 14 38674 39424 31619232
Inappropriate affect 16.84 14.24 10 38678 592 31658064
Neutrophilia 16.70 14.24 22 38666 3821 31654835
Withdrawal syndrome 16.49 14.24 41 38647 11676 31646980
Chest pain 16.48 14.24 80 38608 116877 31541779
Off label use 16.43 14.24 312 38376 346962 31311694
Hypoaesthesia 16.31 14.24 27 38661 55995 31602661
Polydipsia psychogenic 16.28 14.24 6 38682 117 31658539
Diabetic coma 16.15 14.24 11 38677 827 31657829
Hypertonia 16.14 14.24 22 38666 3946 31654710
Long QT syndrome 16.09 14.24 17 38671 2339 31656317
Oromandibular dystonia 16.07 14.24 9 38679 477 31658179
Thought blocking 15.91 14.24 6 38682 125 31658531
Cerebral amyloid angiopathy 15.87 14.24 6 38682 126 31658530
Gastrooesophageal reflux disease 15.79 14.24 11 38677 33860 31624796
Haematuria 15.77 14.24 20 38668 46294 31612362
Lung disorder 15.73 14.24 10 38678 32302 31626354
Electrocardiogram T wave amplitude decreased 15.65 14.24 7 38681 228 31658428
Toxic encephalopathy 15.52 14.24 24 38664 4826 31653830
Neoplasm progression 15.42 14.24 3 38685 20269 31638387
Dysphoria 15.42 14.24 16 38672 2156 31656500
Platelet count decreased 15.29 14.24 76 38612 110359 31548297
Hyperkalaemia 15.28 14.24 35 38653 64316 31594340
Gastrectomy 15.20 14.24 6 38682 142 31658514
Atrioventricular block first degree 15.12 14.24 26 38662 5711 31652945
Wheezing 15.11 14.24 13 38675 35973 31622683
Toxic cardiomyopathy 15.08 14.24 7 38681 249 31658407
Intention tremor 14.99 14.24 8 38680 385 31658271
Oxygen saturation decreased 14.93 14.24 23 38665 49092 31609564
Asthma 14.93 14.24 18 38670 42593 31616063
Chronic obstructive pulmonary disease 14.87 14.24 20 38668 45146 31613510
Acarodermatitis 14.75 14.24 8 38680 398 31658258
Bradykinesia 14.74 14.24 20 38668 3572 31655084
Psychomotor retardation 14.72 14.24 19 38669 3233 31655423
Ascites 14.71 14.24 17 38671 40996 31617660
Metastases to eye 14.66 14.24 5 38683 77 31658579
Hyperleukocytosis 14.60 14.24 14 38674 1715 31656941
Myalgia 14.60 14.24 47 38641 77211 31581445
Muscle contractions involuntary 14.50 14.24 14 38674 1730 31656926
Rhinorrhoea 14.47 14.24 5 38683 23007 31635649
Product dose omission issue 14.42 14.24 73 38615 105513 31553143
Sinus arrest 14.31 14.24 13 38675 1488 31657168

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxicity to various agents 1998.22 13.06 2231 73139 379941 70473133
Tremor 1217.08 13.06 1132 74238 154492 70698582
Antipsychotic drug level increased 1196.34 13.06 375 74995 5065 70848009
Neuroleptic malignant syndrome 1151.45 13.06 559 74811 25448 70827626
Nephrogenic diabetes insipidus 949.06 13.06 250 75120 1713 70851361
Mania 851.06 13.06 399 74971 16775 70836299
Drug interaction 744.80 13.06 1398 73972 380043 70473031
Extrapyramidal disorder 713.33 13.06 376 74994 20374 70832700
Hypomania 472.95 13.06 194 75176 5878 70847196
Antipsychotic drug level above therapeutic 445.80 13.06 139 75231 1840 70851234
Agitation 433.48 13.06 515 74855 92860 70760214
Psychotic disorder 427.76 13.06 340 75030 37361 70815713
Parkinsonism 392.95 13.06 229 75141 15096 70837978
Ataxia 386.82 13.06 264 75106 22953 70830121
Confusional state 381.27 13.06 895 74475 283503 70569571
Serotonin syndrome 376.63 13.06 331 75039 41783 70811291
Hyperparathyroidism 375.69 13.06 136 75234 2911 70850163
Sopor 374.14 13.06 291 75079 30976 70822098
Suicide attempt 361.51 13.06 434 74936 79076 70773998
Completed suicide 349.15 13.06 755 74615 226380 70626694
Bipolar disorder 346.94 13.06 167 75203 7441 70845633
Suicidal ideation 344.80 13.06 397 74973 69199 70783875
Dysarthria 342.11 13.06 375 74995 61938 70791136
Akathisia 337.32 13.06 192 75178 12101 70840973
Schizophrenia 328.58 13.06 211 75159 16557 70836517
Sedation 317.07 13.06 315 75055 46416 70806658
Tardive dyskinesia 277.60 13.06 157 75213 9772 70843302
Salivary hypersecretion 274.12 13.06 171 75199 12754 70840320
Pain 272.71 13.06 166 75204 628650 70224424
Dyspnoea 268.09 13.06 255 75115 769805 70083269
Intentional self-injury 265.55 13.06 240 75130 31410 70821664
Rheumatoid arthritis 256.43 13.06 13 75357 291792 70561282
Muscle rigidity 254.98 13.06 188 75182 18462 70834612
Diabetes insipidus 251.47 13.06 115 75255 4556 70848518
Aggression 251.14 13.06 283 75087 48163 70804911
Hypernatraemia 246.12 13.06 159 75211 12602 70840472
Drug abuse 238.11 13.06 500 74870 146756 70706318
Arthralgia 236.71 13.06 120 75250 503270 70349804
Granulocytopenia 236.29 13.06 145 75225 10502 70842572
Somnolence 232.38 13.06 625 74745 214981 70638093
Catatonia 228.44 13.06 129 75241 8004 70845070
Psychomotor hyperactivity 227.87 13.06 163 75207 15270 70837804
Myoclonus 227.31 13.06 203 75167 26152 70826922
Overdose 222.45 13.06 530 74840 169215 70683859
Obsessive-compulsive disorder 215.36 13.06 108 75262 5262 70847812
Irritability 199.30 13.06 224 75146 38001 70815073
Intentional overdose 196.21 13.06 365 75005 98070 70755004
Delusion 192.38 13.06 161 75209 19004 70834070
Delirium 192.33 13.06 310 75060 74304 70778770
Hallucination, auditory 186.11 13.06 155 75215 18173 70834901
Disorientation 180.78 13.06 263 75107 57660 70795414
Dyskinesia 179.71 13.06 220 75150 40854 70812220
Disturbance in attention 175.26 13.06 222 75148 42672 70810402
Drug level increased 157.38 13.06 194 75176 36275 70816799
Mental status changes 155.60 13.06 257 75113 62844 70790230
Infusion related reaction 150.42 13.06 17 75353 197517 70655557
Hyperreflexia 149.13 13.06 95 75275 7347 70845727
Schizoaffective disorder 148.61 13.06 62 75308 1961 70851113
Polyuria 145.80 13.06 118 75252 13288 70839786
Coma 143.87 13.06 308 75062 91536 70761538
Febrile neutropenia 142.73 13.06 23 75347 204295 70648779
Cough 140.54 13.06 86 75284 325291 70527783
Hypothyroidism 138.77 13.06 205 75165 45550 70807524
Restlessness 138.34 13.06 196 75174 41932 70811142
Neurotoxicity 137.39 13.06 164 75206 29662 70823412
Speech disorder 136.98 13.06 215 75155 50365 70802709
Dystonia 135.75 13.06 134 75236 19572 70833502
Altered state of consciousness 135.58 13.06 189 75181 39833 70813241
Anaemia 133.70 13.06 139 75231 403284 70449790
Joint swelling 133.56 13.06 51 75319 253160 70599914
Depressed level of consciousness 133.27 13.06 290 75080 87141 70765933
Electrocardiogram QT prolonged 129.56 13.06 279 75091 83238 70769836
Antipsychotic drug level below therapeutic 129.08 13.06 46 75324 939 70852135
Abnormal behaviour 125.24 13.06 169 75201 34540 70818534
Hypersensitivity 125.06 13.06 44 75326 229768 70623306
Pruritus 125.04 13.06 110 75260 345450 70507624
Polydipsia 123.88 13.06 78 75292 5910 70847164
Synovitis 122.97 13.06 3 75367 129225 70723849
Pain in extremity 115.63 13.06 107 75263 327975 70525099
Weight increased 114.22 13.06 535 74835 241796 70611278
Peripheral swelling 111.54 13.06 56 75314 236507 70616567
Pleurothotonus 111.09 13.06 53 75317 2313 70850761
Cognitive disorder 110.28 13.06 217 75153 60739 70792335
Depression 110.19 13.06 461 74909 198513 70654561
Swelling 109.84 13.06 32 75338 188507 70664567
Brugada syndrome 108.76 13.06 42 75328 1081 70851993
Back pain 104.63 13.06 81 75289 271071 70582003
Fatigue 104.07 13.06 487 74883 823832 70029242
Cerebellar syndrome 102.89 13.06 66 75304 5165 70847909
Bradyphrenia 102.81 13.06 85 75285 9861 70843213
Arthropathy 102.32 13.06 18 75352 150039 70703035
Disease progression 102.15 13.06 21 75349 156651 70696423
Blood creatine phosphokinase increased 101.19 13.06 210 75160 61053 70792021
Rash 100.97 13.06 248 75122 510314 70342760
Euphoric mood 99.94 13.06 72 75298 6817 70846257
Bruxism 98.95 13.06 57 75313 3672 70849402
Sinusitis 98.03 13.06 29 75341 169166 70683908
Nasopharyngitis 96.91 13.06 58 75312 222148 70630926
Malignant neoplasm progression 96.47 13.06 9 75361 121730 70731344
White blood cell count increased 95.08 13.06 221 75149 69352 70783722
Nephropathy 94.53 13.06 77 75293 8748 70844326
Logorrhoea 91.20 13.06 56 75314 4058 70849016
Systemic lupus erythematosus 91.16 13.06 4 75366 101898 70751176
Bipolar I disorder 90.19 13.06 43 75327 1874 70851200
Apathy 89.59 13.06 85 75285 11823 70841251
Encephalopathy 88.83 13.06 200 75170 61461 70791613
Treatment noncompliance 88.14 13.06 169 75201 46405 70806669
Leukocytosis 87.77 13.06 154 75216 39514 70813560
Alopecia 87.69 13.06 51 75319 198439 70654635
Atrial fibrillation 84.85 13.06 45 75325 184303 70668771
Neutrophil count increased 84.05 13.06 122 75248 26673 70826401
Priapism 83.68 13.06 53 75317 4057 70849017
Drug intolerance 82.59 13.06 71 75299 225616 70627458
Death 82.26 13.06 273 75097 509788 70343286
Camptocormia 80.62 13.06 27 75343 454 70852620
Stomatitis 80.18 13.06 19 75351 128492 70724582
Anxiety 79.78 13.06 452 74918 219878 70633196
Jaundice cholestatic 79.68 13.06 71 75299 9113 70843961
Interstitial lung disease 79.68 13.06 9 75361 104676 70748398
Grandiosity 79.48 13.06 28 75342 552 70852522
Pneumonia 79.43 13.06 345 75025 595887 70257187
Hypercalcaemia 79.35 13.06 136 75234 34249 70818825
Depressed mood 79.25 13.06 156 75214 43664 70809410
Hand deformity 78.68 13.06 3 75367 86479 70766595
Enuresis 78.50 13.06 45 75325 2872 70850202
Cogwheel rigidity 77.78 13.06 45 75325 2923 70850151
Coordination abnormal 76.72 13.06 90 75280 15976 70837098
Contraindicated product administered 76.29 13.06 24 75346 134588 70718486
Infection 76.29 13.06 67 75303 210718 70642356
Libido increased 76.15 13.06 38 75332 1831 70851243
Oppositional defiant disorder 75.89 13.06 26 75344 470 70852604
Poisoning deliberate 75.60 13.06 92 75278 16968 70836106
Mutism 74.54 13.06 39 75331 2077 70850997
Renal cyst 74.36 13.06 81 75289 13264 70839810
Clonus 74.20 13.06 58 75312 6210 70846864
Affect lability 73.63 13.06 71 75299 10075 70842999
Mental disorder 73.63 13.06 118 75252 28122 70824952
Cardiac failure congestive 73.54 13.06 26 75344 135431 70717643
Arthritis 73.14 13.06 9 75361 97971 70755103
Homicidal ideation 73.07 13.06 45 75325 3278 70849796
Paranoia 73.02 13.06 91 75279 17197 70835877
Glossodynia 72.40 13.06 5 75365 86482 70766592
Choreoathetosis 71.30 13.06 34 75336 1482 70851592
Parathyroid tumour benign 70.10 13.06 27 75343 690 70852384
Headache 70.09 13.06 348 75022 580057 70273017
Poisoning 69.50 13.06 102 75268 22520 70830554
Withdrawal syndrome 68.99 13.06 107 75263 24797 70828277
Body tinea 68.06 13.06 32 75338 1351 70851723
Pericarditis 67.81 13.06 6 75364 84699 70768375
Gastrointestinal haemorrhage 67.06 13.06 31 75339 137377 70715697
Wound 66.95 13.06 12 75358 98720 70754354
Aphasia 65.34 13.06 143 75227 43106 70809968
Electroencephalogram abnormal 65.18 13.06 50 75320 5208 70847866
Bradykinesia 65.09 13.06 58 75312 7444 70845630
Urticaria 65.05 13.06 47 75323 163002 70690072
Hyperparathyroidism primary 64.56 13.06 22 75348 391 70852683
Abdominal discomfort 64.43 13.06 80 75290 214578 70638496
Hyperprolactinaemia 63.74 13.06 46 75324 4367 70848707
Intentional product use issue 63.62 13.06 24 75346 120118 70732956
Insomnia 62.57 13.06 421 74949 217385 70635689
Decreased eye contact 62.50 13.06 26 75344 816 70852258
Pyramidal tract syndrome 62.06 13.06 23 75347 527 70852547
Increased appetite 61.91 13.06 66 75304 10547 70842527
Stupor 61.86 13.06 53 75317 6456 70846618
Thinking abnormal 61.73 13.06 70 75300 11981 70841093
Drooling 61.55 13.06 49 75321 5387 70847687
Sepsis 59.87 13.06 105 75265 244440 70608634
Drug level above therapeutic 59.65 13.06 56 75314 7686 70845388
Psychiatric decompensation 59.52 13.06 38 75332 2949 70850125
Thrombocytopenia 59.14 13.06 102 75268 239008 70614066
Postural tremor 58.98 13.06 23 75347 608 70852466
Gait disturbance 57.54 13.06 365 75005 184741 70668333
Abdominal pain 57.24 13.06 180 75190 341947 70511127
Chronic kidney disease 56.79 13.06 168 75202 60889 70792185
General physical health deterioration 56.29 13.06 103 75267 235928 70617146
Hostility 55.95 13.06 33 75337 2222 70850852
Disinhibition 55.33 13.06 33 75337 2268 70850806
Myocarditis 55.24 13.06 83 75287 18710 70834364
Diarrhoea 55.02 13.06 550 74820 782791 70070283
Asthma 54.81 13.06 30 75340 120763 70732311
Neuropathy peripheral 54.07 13.06 34 75336 126862 70726212
Plasma cell myeloma 53.96 13.06 7 75363 73194 70779880
Leukopenia 53.63 13.06 240 75130 106320 70746754
Therapeutic product effect decreased 53.51 13.06 44 75326 142974 70710100
Drug reaction with eosinophilia and systemic symptoms 53.36 13.06 159 75211 57854 70795220
Myocardial infarction 52.52 13.06 63 75307 171582 70681492
Hypertonia 51.99 13.06 48 75322 6450 70846624
Bronchitis 51.93 13.06 30 75340 117213 70735861
Lethargy 51.91 13.06 187 75183 75063 70778011
Blister 51.71 13.06 21 75349 100505 70752569
Anger 51.39 13.06 74 75296 16058 70837016
Chest pain 51.17 13.06 120 75250 251140 70601934
Pressure of speech 51.09 13.06 24 75346 1011 70852063
Persistent depressive disorder 50.96 13.06 24 75346 1017 70852057
Impaired healing 50.51 13.06 9 75361 74365 70778709
Poor quality sleep 50.29 13.06 83 75287 20266 70832808
Glucose tolerance impaired 50.09 13.06 48 75322 6758 70846316
Anticholinergic syndrome 49.88 13.06 34 75336 2946 70850128
Blood prolactin increased 49.41 13.06 37 75333 3717 70849357
Acute kidney injury 49.20 13.06 742 74628 473882 70379192
Injection site erythema 49.15 13.06 9 75361 72915 70780159
Dystonic tremor 48.70 13.06 15 75355 190 70852884
Abdominal pain upper 48.40 13.06 82 75288 193520 70659554
Treatment failure 48.39 13.06 49 75321 144093 70708981
Galactorrhoea 48.30 13.06 35 75335 3343 70849731
Urinary incontinence 48.21 13.06 117 75253 37725 70815349
Blood sodium increased 48.01 13.06 39 75331 4413 70848661
Major depression 47.70 13.06 52 75318 8522 70844552
Mental impairment 47.60 13.06 74 75296 17181 70835893
Gestational diabetes 47.37 13.06 44 75326 5957 70847117
Depressive symptom 46.84 13.06 41 75329 5140 70847934
Hyperthermia 46.70 13.06 72 75298 16599 70836475
Musculoskeletal pain 46.25 13.06 19 75351 90308 70762766
Distractibility 45.90 13.06 20 75350 705 70852369
Schizoaffective disorder bipolar type 45.62 13.06 14 75356 175 70852899
Psychiatric symptom 45.42 13.06 45 75325 6599 70846475
Infection susceptibility increased 45.41 13.06 32 75338 2925 70850149
Bundle branch block right 45.05 13.06 56 75314 10554 70842520
Behaviour disorder 44.96 13.06 41 75329 5423 70847651
Pancytopenia 44.61 13.06 57 75313 151050 70702024
Inhibitory drug interaction 44.57 13.06 35 75335 3772 70849302
Mucosal inflammation 44.40 13.06 9 75361 67841 70785233
Ascites 44.12 13.06 9 75361 67538 70785536
Muscle contractions involuntary 44.04 13.06 33 75337 3318 70849756
Electroconvulsive therapy 44.02 13.06 12 75358 95 70852979
Muscle twitching 43.88 13.06 77 75293 19750 70833324
Psoriatic arthropathy 43.63 13.06 8 75362 64763 70788311
Metabolic syndrome 43.24 13.06 29 75341 2446 70850628
Balance disorder 43.11 13.06 200 75170 89928 70763146
International normalised ratio increased 42.95 13.06 16 75354 80710 70772364
Cardio-respiratory arrest 42.83 13.06 216 75154 100461 70752613
Productive cough 42.57 13.06 15 75355 78322 70774752
Drug hypersensitivity 42.54 13.06 140 75230 262319 70590755
Renal oncocytoma 42.44 13.06 11 75359 70 70853004
Tachycardia 42.27 13.06 301 75069 158245 70694829
Hyperthyroidism 41.87 13.06 76 75294 20015 70833059
Action tremor 41.68 13.06 16 75354 405 70852669
Delusion of grandeur 41.62 13.06 20 75350 887 70852187
Hallucination 41.60 13.06 176 75194 76084 70776990
Trismus 41.49 13.06 38 75332 5053 70848021
Gastrointestinal disorder 41.25 13.06 31 75339 105396 70747678
Electrocardiogram T wave abnormal 41.07 13.06 32 75338 3410 70849664
Abulia 41.04 13.06 20 75350 915 70852159
Mobility decreased 40.66 13.06 30 75340 102969 70750105
Hypothermia 40.52 13.06 76 75294 20518 70832556
Mood altered 40.44 13.06 67 75303 16408 70836666
Blunted affect 40.44 13.06 16 75354 440 70852634
Oedema peripheral 40.27 13.06 117 75253 227974 70625100
Osteoarthritis 38.94 13.06 15 75355 74132 70778942
Asterixis 38.77 13.06 27 75343 2422 70850652
Sexually inappropriate behaviour 38.56 13.06 16 75354 499 70852575
Resting tremor 38.38 13.06 22 75348 1404 70851670
Pleural effusion 38.31 13.06 51 75319 132813 70720261
Miosis 38.24 13.06 60 75310 14041 70839033
Visuospatial deficit 38.19 13.06 9 75361 36 70853038
Electrocardiogram T wave inversion 38.01 13.06 36 75334 4995 70848079
Melaena 37.88 13.06 7 75363 56348 70796726
Cerebellar atrophy 37.86 13.06 20 75350 1086 70851988
Haemodialysis 37.86 13.06 67 75303 17299 70835775
Acute myocardial infarction 37.85 13.06 15 75355 72872 70780202
Malaise 37.83 13.06 287 75083 432645 70420429
Haemorrhage 37.75 13.06 21 75349 83794 70769280
Agranulocytosis 37.58 13.06 111 75259 40187 70812887
Affective disorder 37.56 13.06 43 75327 7436 70845638
Cerebrovascular accident 37.50 13.06 59 75311 143411 70709663
Memory impairment 37.48 13.06 196 75174 92445 70760629
Failure to suspend medication 37.10 13.06 15 75355 437 70852637
Psychomotor skills impaired 36.93 13.06 33 75337 4251 70848823
Personality disorder 36.86 13.06 37 75333 5511 70847563
Cardiac failure 36.61 13.06 60 75310 143481 70709593
Lung disorder 36.58 13.06 14 75356 69470 70783604
Electrocardiogram abnormal 36.49 13.06 60 75310 14604 70838470
Oculogyric crisis 36.42 13.06 27 75343 2671 70850403
Hypokinesia 36.40 13.06 66 75304 17366 70835708
Long QT syndrome 36.27 13.06 36 75334 5291 70847783
Pneumonitis 36.23 13.06 7 75363 54590 70798484
Septic shock 35.62 13.06 40 75330 112218 70740856
Rhinorrhoea 35.57 13.06 13 75357 66358 70786716
Epistaxis 35.47 13.06 34 75336 102593 70750481
Persecutory delusion 35.43 13.06 33 75337 4484 70848590
Antipsychotic drug level decreased 35.38 13.06 19 75351 1067 70852007
Discomfort 35.21 13.06 36 75334 105400 70747674
Anaphylactic reaction 34.92 13.06 18 75352 74956 70778118
Psychomotor retardation 34.77 13.06 36 75334 5562 70847512
Soft tissue injury 34.54 13.06 22 75348 1700 70851374
Blood pressure fluctuation 34.37 13.06 10 75360 59002 70794072
Lower respiratory tract infection 34.30 13.06 41 75329 111872 70741202
Electrocardiogram QRS complex prolonged 34.23 13.06 47 75323 9759 70843315
Language disorder 34.19 13.06 27 75343 2934 70850140
Injection site pain 34.06 13.06 45 75325 117574 70735500
Impulsive behaviour 33.72 13.06 26 75344 2728 70850346
Sleep-related eating disorder 33.65 13.06 16 75354 693 70852381
Feeling guilty 33.59 13.06 17 75353 844 70852230
Goitre 33.50 13.06 34 75336 5132 70847942
Acute psychosis 33.43 13.06 30 75340 3886 70849188
Dyspnoea exertional 33.42 13.06 21 75349 78409 70774665
Self-injurious ideation 33.40 13.06 28 75342 3310 70849764
Platelet count decreased 33.24 13.06 89 75281 178133 70674941
Otospondylomegaepiphyseal dysplasia 33.01 13.06 8 75362 37 70853037
Sluggishness 32.98 13.06 36 75334 5907 70847167
Social avoidant behaviour 32.69 13.06 32 75338 4624 70848450
Hyperkinesia 32.64 13.06 25 75345 2598 70850476
Restless legs syndrome 32.58 13.06 65 75305 18363 70834711
Nausea 32.55 13.06 675 74695 851413 70001661
Hypomagnesaemia 32.32 13.06 3 75367 40761 70812313
Feelings of worthlessness 32.31 13.06 14 75356 487 70852587
Nodal rhythm 32.21 13.06 26 75344 2915 70850159
Decreased appetite 32.13 13.06 191 75179 304589 70548485
Fibromyalgia 32.06 13.06 6 75364 47868 70805206
Blood thyroid stimulating hormone decreased 31.96 13.06 34 75336 5420 70847654
Neoplasm progression 31.76 13.06 5 75365 45223 70807851
Erythema 31.26 13.06 108 75262 199455 70653619
Product use issue 31.24 13.06 93 75277 179844 70673230
Adams-Stokes syndrome 31.16 13.06 10 75360 146 70852928
Muscle spasms 31.00 13.06 74 75296 153972 70699102
Coronary artery disease 30.83 13.06 14 75356 62722 70790352
Patient restraint 30.63 13.06 9 75361 96 70852978
Speech sound disorder 30.59 13.06 8 75362 53 70853021
Neutrophilia 30.47 13.06 38 75332 7183 70845891
Differential white blood cell count abnormal 30.32 13.06 21 75349 1867 70851207
Protein C increased 30.13 13.06 9 75361 102 70852972
Sinus bradycardia 30.05 13.06 73 75297 23550 70829524
Paraesthesia 30.01 13.06 69 75301 145468 70707606
Apraxia 29.98 13.06 24 75346 2659 70850415
Oncocytoma 29.90 13.06 7 75363 27 70853047
Dysphemia 29.85 13.06 26 75344 3237 70849837
Hallucination, olfactory 29.84 13.06 13 75357 458 70852616
Tachyphrenia 29.70 13.06 21 75349 1930 70851144
Post-traumatic neck syndrome 29.49 13.06 21 75349 1952 70851122
Wheezing 29.39 13.06 34 75336 94136 70758938
Hyporeflexia 29.28 13.06 26 75344 3321 70849753
Urinary retention 29.25 13.06 122 75248 52398 70800676
Echolalia 29.11 13.06 12 75358 368 70852706
Upper gastrointestinal haemorrhage 29.08 13.06 3 75367 37474 70815600
Metabolic encephalopathy 29.07 13.06 40 75330 8323 70844751
Chest discomfort 28.99 13.06 55 75315 124326 70728748
Haematoma 28.57 13.06 8 75362 48410 70804664
Drug withdrawal syndrome 28.51 13.06 88 75282 32627 70820447
Hyperhidrosis 28.48 13.06 238 75132 131348 70721726
Skin ulcer 28.33 13.06 8 75362 48137 70804937
Respiratory arrest 28.28 13.06 123 75247 53810 70799264
Haemoglobin decreased 28.26 13.06 117 75253 205042 70648032
Psoriasis 28.15 13.06 38 75332 98395 70754679
Dysphoria 28.07 13.06 29 75341 4469 70848605
Antipsychotic drug level 27.88 13.06 6 75364 14 70853060
Parkinsonian gait 27.82 13.06 15 75355 849 70852225
Osteonecrosis of jaw 27.76 13.06 5 75365 40997 70812077
Papillary thyroid cancer 27.64 13.06 22 75348 2418 70850656
Influenza 27.63 13.06 49 75321 113651 70739423
Hyperleukocytosis 27.43 13.06 21 75349 2180 70850894
Poverty of speech 27.28 13.06 13 75357 566 70852508
Thrombosis 27.21 13.06 24 75346 75381 70777693
Bone pain 27.15 13.06 10 75360 50812 70802262
COVID-19 27.15 13.06 44 75326 105713 70747361
Off label use 27.06 13.06 593 74777 742467 70110607
Sleep disorder 27.01 13.06 146 75224 69726 70783348
Movement disorder 26.97 13.06 71 75299 24058 70829016
Convulsive threshold lowered 26.88 13.06 15 75355 909 70852165
Angina pectoris 26.74 13.06 9 75361 48374 70804700
Hypoxia 26.73 13.06 36 75334 93308 70759766
Seizure 26.71 13.06 298 75072 177664 70675410
Upper respiratory tract infection 26.54 13.06 27 75343 79247 70773827
Toxic encephalopathy 26.46 13.06 43 75327 10363 70842711
Blood pressure increased 26.28 13.06 107 75263 188410 70664664
Sternal fracture 26.21 13.06 21 75349 2330 70850744
Sinus arrest 26.21 13.06 24 75346 3191 70849883
Haemoptysis 26.05 13.06 11 75359 51441 70801633
Deprescribing error 25.87 13.06 6 75364 22 70853052
Oxygen saturation decreased 25.82 13.06 53 75317 116376 70736698
Acquired cystic kidney disease 25.73 13.06 7 75363 55 70853019
Injection site swelling 25.71 13.06 7 75363 43150 70809924
Nystagmus 25.64 13.06 40 75330 9315 70843759
Hypoaesthesia 25.59 13.06 81 75289 153658 70699416
Hyperammonaemia 25.45 13.06 42 75328 10251 70842823
Gaze palsy 25.42 13.06 22 75348 2716 70850358
Antidepressant drug level increased 25.14 13.06 11 75359 392 70852682
Induced abortion failed 25.06 13.06 9 75361 188 70852886
Inflammation 24.99 13.06 28 75342 78637 70774437
Cerebral haemorrhage 24.98 13.06 13 75357 53851 70799223
Neurological symptom 24.86 13.06 35 75335 7438 70845636
Staphylococcal infection 24.60 13.06 13 75357 53391 70799683
Hereditary ataxia 24.54 13.06 6 75364 29 70853045
Diverticulitis 24.43 13.06 7 75363 41727 70811347
Nephropathy toxic 24.39 13.06 58 75312 18456 70834618
Fluid retention 24.33 13.06 19 75351 63366 70789708
Status epilepticus 24.26 13.06 69 75301 24457 70828617
Electric shock sensation 23.88 13.06 12 75358 587 70852487
Myocarditis septic 23.45 13.06 6 75364 36 70853038
Crying 23.31 13.06 62 75308 21137 70831937
Flat affect 23.21 13.06 18 75352 1905 70851169
Chronic obstructive pulmonary disease 23.20 13.06 29 75341 77612 70775462
Blood creatinine increased 23.09 13.06 243 75127 142758 70710316
Gambling disorder 23.09 13.06 18 75352 1920 70851154
Injection site bruising 22.98 13.06 6 75364 38026 70815048
Hallucinations, mixed 22.97 13.06 31 75339 6331 70846743
Substance abuse 22.81 13.06 39 75331 9798 70843276
Gastric disorder 22.69 13.06 4 75366 33318 70819756
Conversion disorder 22.50 13.06 17 75353 1731 70851343
Osteomyelitis 22.10 13.06 3 75367 30315 70822759
Lactic acidosis 21.93 13.06 22 75348 65002 70788072
Cholelithiasis 21.86 13.06 104 75266 47236 70805838
Sexual dysfunction 21.80 13.06 31 75339 6650 70846424
Mydriasis 21.71 13.06 51 75319 16102 70836972
Progressive supranuclear palsy 21.70 13.06 7 75363 104 70852970
Cerebellar ataxia 21.69 13.06 17 75353 1827 70851247
Drug level decreased 21.69 13.06 44 75326 12580 70840494
Mood swings 21.67 13.06 55 75315 18231 70834843
Knee arthroplasty 21.52 13.06 5 75365 34296 70818778
Thought blocking 21.32 13.06 8 75362 190 70852884
Flight of ideas 21.25 13.06 12 75358 744 70852330
Haematochezia 21.11 13.06 28 75342 73053 70780021
Water intoxication 21.06 13.06 12 75358 757 70852317
Haematuria 20.89 13.06 22 75348 63551 70789523
Clostridium difficile colitis 20.83 13.06 3 75367 28993 70824081
Cystitis 20.79 13.06 12 75358 46929 70806145
Medication error 20.71 13.06 117 75253 56795 70796279
Eosinophil count decreased 20.69 13.06 20 75350 2846 70850228
Prostate cancer 20.67 13.06 4 75366 31159 70821915
Ileus paralytic 20.67 13.06 35 75335 8726 70844348
Negativism 20.54 13.06 12 75358 794 70852280
Hypokalaemia 20.53 13.06 71 75299 131117 70721957
Throat irritation 20.52 13.06 6 75364 35298 70817776
Localised infection 20.48 13.06 5 75365 33153 70819921
Encopresis 20.46 13.06 7 75363 126 70852948
Suspected suicide 20.45 13.06 35 75335 8799 70844275
Clear cell renal cell carcinoma 20.32 13.06 18 75352 2292 70850782
Ear infection 20.20 13.06 3 75367 28333 70824741
Reflexes abnormal 20.18 13.06 12 75358 820 70852254
Weight decreased 20.05 13.06 222 75148 310266 70542808
Myelosuppression 19.72 13.06 4 75366 30141 70822933
Delusion of reference 19.64 13.06 7 75363 143 70852931
Oropharyngeal pain 19.58 13.06 46 75324 96264 70756810
Bipolar II disorder 19.39 13.06 9 75361 369 70852705
Lactate pyruvate ratio increased 19.27 13.06 6 75364 79 70852995
Atrioventricular block first degree 19.24 13.06 40 75330 11633 70841441
Ideas of reference 19.15 13.06 7 75363 154 70852920
Muscle contracture 19.11 13.06 17 75353 2177 70850897
Intention tremor 19.03 13.06 11 75359 713 70852361
Maternal exposure during pregnancy 19.03 13.06 61 75309 115284 70737790
Torticollis 19.01 13.06 17 75353 2192 70850882
Abdominal distension 18.96 13.06 53 75317 104616 70748458
Bacteraemia 18.94 13.06 4 75366 29305 70823769
Cerebral atrophy 18.94 13.06 31 75339 7516 70845558
Impaired quality of life 18.92 13.06 34 75336 8882 70844192
Myalgia 18.86 13.06 103 75267 167789 70685285
Dry skin 18.78 13.06 19 75351 55912 70797162
Hallucination, visual 18.62 13.06 71 75299 29266 70823808
Autonomic nervous system imbalance 18.58 13.06 23 75347 4316 70848758
Irritable bowel syndrome 18.57 13.06 16 75354 50834 70802240
Diabetic coma 18.53 13.06 13 75357 1180 70851894
Therapeutic product effect variable 18.48 13.06 15 75355 1695 70851379
Pulmonary arterial hypertension 18.35 13.06 6 75364 32849 70820225
Osteoporosis 18.34 13.06 15 75355 48892 70804182
Thyrotoxic crisis 18.27 13.06 13 75357 1207 70851867
Thyroiditis 18.26 13.06 22 75348 4014 70849060
Rectal haemorrhage 18.23 13.06 26 75344 65805 70787269
Product dose omission issue 18.09 13.06 146 75224 217322 70635752
Rhabdomyolysis 18.02 13.06 168 75202 95592 70757482
Oscillopsia 17.99 13.06 7 75363 184 70852890
Ill-defined disorder 17.92 13.06 19 75351 54722 70798352
Histrionic personality disorder 17.88 13.06 5 75365 44 70853030
Dysphagia 17.87 13.06 191 75179 112643 70740431
Femur fracture 17.85 13.06 8 75362 36124 70816950
Hyperkalaemia 17.84 13.06 56 75314 106535 70746539
Pulmonary oedema 17.78 13.06 38 75332 82240 70770834
Angioedema 17.77 13.06 27 75343 66583 70786491
Colitis ulcerative 17.58 13.06 7 75363 33916 70819158
Blood thyroid stimulating hormone increased 17.57 13.06 32 75338 8447 70844627
Unmasking of previously unidentified disease 17.47 13.06 15 75355 1832 70851242
Prescribed overdose 17.44 13.06 66 75304 27115 70825959
Megacolon 17.31 13.06 19 75351 3137 70849937
Urinary tract infection 17.22 13.06 175 75195 248594 70604480
Secondary tic 17.18 13.06 4 75366 15 70853059
Impaired work ability 17.17 13.06 47 75323 16293 70836781
Social anxiety disorder 17.08 13.06 9 75361 486 70852588
Irregular sleep wake rhythm disorder 16.96 13.06 8 75362 340 70852734
High-grade B-cell lymphoma 16.91 13.06 7 75363 217 70852857
Urine output increased 16.89 13.06 15 75355 1916 70851158
Osteonecrosis 16.87 13.06 5 75365 29155 70823919
Hepatic failure 16.72 13.06 22 75348 57603 70795471
Compulsions 16.71 13.06 8 75362 352 70852722
Bradycardia 16.61 13.06 204 75166 124411 70728663
Blood citric acid increased 16.56 13.06 5 75365 59 70853015
Hepatic cirrhosis 16.50 13.06 6 75364 30725 70822349
Blood pressure systolic increased 16.47 13.06 22 75348 57237 70795837
Merycism 16.39 13.06 7 75363 235 70852839
Mouth ulceration 16.36 13.06 8 75362 34341 70818733
Obesity 16.35 13.06 64 75306 26707 70826367
Dialysis 16.28 13.06 48 75322 17354 70835720
Dry eye 16.18 13.06 7 75363 32275 70820799
Pain in jaw 16.11 13.06 13 75357 42656 70810418
Device related infection 16.10 13.06 7 75363 32178 70820896
Hip fracture 16.07 13.06 5 75365 28258 70824816
Generalised tonic-clonic seizure 16.06 13.06 87 75283 41574 70811500
Fungal infection 16.00 13.06 10 75360 37457 70815617
Diabetic hyperosmolar coma 15.98 13.06 10 75360 749 70852325
Nephrolithiasis 15.97 13.06 16 75354 47307 70805767
Decreased interest 15.97 13.06 19 75351 3422 70849652
Pulmonary mass 15.93 13.06 4 75366 26029 70827045
Psychotic symptom 15.72 13.06 16 75354 2422 70850652
Hepatotoxicity 15.72 13.06 90 75280 43896 70809178
Clostridium difficile infection 15.71 13.06 11 75359 38805 70814269
Limbic encephalitis 15.66 13.06 10 75360 776 70852298
Staring 15.62 13.06 16 75354 2440 70850634
Injection site haemorrhage 15.47 13.06 4 75366 25523 70827551
Activation syndrome 15.45 13.06 7 75363 271 70852803
Eosinophilia 15.41 13.06 84 75286 40235 70812839
Blood triglycerides increased 15.41 13.06 51 75319 19613 70833461
Electrocardiogram T wave amplitude decreased 15.38 13.06 9 75361 597 70852477
Flatulence 15.22 13.06 11 75359 38170 70814904
International normalised ratio abnormal 15.17 13.06 23 75347 5224 70847850
Psychotic disorder due to a general medical condition 15.17 13.06 7 75363 283 70852791
Antidepressant drug level above therapeutic 15.10 13.06 9 75361 618 70852456
Hyperammonaemic encephalopathy 15.07 13.06 21 75349 4422 70848652
Acute myeloid leukaemia 15.05 13.06 7 75363 30933 70822141
Metabolic disorder 14.99 13.06 29 75341 8011 70845063
Therapy interrupted 14.82 13.06 4 75366 24798 70828276
Respiratory distress 14.73 13.06 22 75348 54628 70798446
Small intestinal obstruction 14.68 13.06 4 75366 24651 70828423
Potentiating drug interaction 14.68 13.06 29 75341 8135 70844939
Sciatica 14.66 13.06 4 75366 24623 70828451
Thyroid function test abnormal 14.66 13.06 17 75353 2980 70850094
Full blood count abnormal 14.53 13.06 9 75361 33869 70819205
Sleep apnoea syndrome 14.48 13.06 71 75299 32642 70820432
Incoherent 14.42 13.06 27 75343 7279 70845795
Basal cell carcinoma 14.38 13.06 9 75361 33689 70819385
Impaired self-care 14.37 13.06 15 75355 2339 70850735
Pneumocystis jirovecii pneumonia 14.34 13.06 7 75363 30075 70822999
Autoimmune thyroiditis 14.30 13.06 19 75351 3823 70849251
Breast cancer 14.27 13.06 9 75361 33540 70819534
Tic 14.21 13.06 16 75354 2717 70850357
Obstructive airways disorder 14.18 13.06 5 75365 26108 70826966
Coagulopathy 14.03 13.06 9 75361 33240 70819834
Fluid intake reduced 14.03 13.06 23 75347 5584 70847490
Body mass index increased 14.00 13.06 13 75357 1759 70851315
Cerebral infarction 14.00 13.06 15 75355 42994 70810080
Consciousness fluctuating 13.98 13.06 13 75357 1763 70851311
Refusal of treatment by patient 13.93 13.06 29 75341 8441 70844633
Cyclothymic disorder 13.89 13.06 6 75364 207 70852867
Polydipsia psychogenic 13.84 13.06 6 75364 209 70852865
Parasomnia 13.81 13.06 8 75362 521 70852553
Tension 13.61 13.06 19 75351 4005 70849069
Cardiac hypertrophy 13.53 13.06 12 75358 1530 70851544
Toxic cardiomyopathy 13.53 13.06 7 75363 364 70852710
Oral pain 13.50 13.06 7 75363 29059 70824015
Slow speech 13.44 13.06 14 75356 2178 70850896
Anaphylactic shock 13.43 13.06 9 75361 32481 70820593
Hypersexuality 13.39 13.06 12 75358 1551 70851523
Neoplasm malignant 13.26 13.06 7 75363 28767 70824307
Dyslipidaemia 13.11 13.06 31 75339 9829 70843245
Obsessive thoughts 13.11 13.06 10 75360 1033 70852041
Bone density decreased 13.06 13.06 34 75336 11440 70841634

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N05AN01 NERVOUS SYSTEM
PSYCHOLEPTICS
ANTIPSYCHOTICS
Lithium
CHEBI has role CHEBI:35477 antimanic drugs
MeSH PA D000928 Antidepressive Agents
MeSH PA D018692 Antimanic Agents
MeSH PA D002491 Central Nervous System Agents
MeSH PA D002492 Central Nervous System Depressants
MeSH PA D004791 Enzyme Inhibitors
MeSH PA D011619 Psychotropic Drugs
MeSH PA D014149 Tranquilizing Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Bipolar disorder indication 13746004 DOID:3312
Pain indication 22253000
Rheumatoid arthritis indication 69896004 DOID:7148
Bipolar disorder in remission indication 85248005
Bipolar affective disorder, current episode manic indication 191618007
Headache disorder indication 230461009
Dysmenorrhea indication 266599000
Fever indication 386661006
Osteoarthritis indication 396275006
Juvenile rheumatoid arthritis indication 410795001
Vascular headache off-label use 128187005
Bipolar affective disorder, current episode depression off-label use 191627008 DOID:3312
Cluster Headache Prevention off-label use
Rapid Cycling Bipolar Affective Disorder off-label use
Psoriasis contraindication 9014002 DOID:8893
Diabetes insipidus contraindication 15771004 DOID:9409
Polyuria contraindication 28442001
Hypothyroidism contraindication 40930008 DOID:1459
Conduction disorder of the heart contraindication 44808001
Chronic heart failure contraindication 48447003
Acute infectious disease contraindication 63171007
Hyponatremia contraindication 89627008
Kidney disease contraindication 90708001 DOID:557
Organic mental disorder contraindication 111479008
Plaque psoriasis contraindication 200965009
Pregnancy, function contraindication 289908002
Breastfeeding (mother) contraindication 413712001
Severe dehydration contraindication 450316000
Lithium Toxicity contraindication




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Glycogen synthase kinase-3 Kinase INHIBITOR CHEMBL CHEMBL
Inositol-1(or 4)-monophosphatase 1 Enzyme INHIBITOR CHEMBL CHEMBL

External reference:

IDSource
4018007 VUID
N0000146351 NUI
D00801 KEGG_DRUG
4018007 VANDF
4019803 VANDF
C0085217 UMLSCUI
CHEBI:6504 CHEBI
CHEBI:30145 CHEBI
CHEMBL1200826 ChEMBL_ID
D016651 MESH_DESCRIPTOR_UI
DB14509 DRUGBANK_ID
2BMD2GNA4V UNII
11125 PUBCHEM_CID
42351 RXNORM
1990 MMSL
4986 MMSL
d00061 MMSL
001532 NDDF
001533 NDDF
16977003 SNOMEDCT_US
321719003 SNOMEDCT_US
387095003 SNOMEDCT_US
85899009 SNOMEDCT_US
C0023870 UMLSCUI
CHEMBL2146126 ChEMBL_ID
7439-93-2 SECONDARY_CAS_RN
D008094 MESH_DESCRIPTOR_UI
3028194 PUBCHEM_CID
9FN79X2M3F UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-0020 TABLET, EXTENDED RELEASE 450 mg ORAL ANDA 16 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-0020 TABLET, EXTENDED RELEASE 450 mg ORAL ANDA 16 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-0021 TABLET, EXTENDED RELEASE 300 mg ORAL ANDA 13 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-0021 TABLET, EXTENDED RELEASE 300 mg ORAL ANDA 13 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-2526 CAPSULE, GELATIN COATED 150 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-2526 CAPSULE, GELATIN COATED 150 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-2527 CAPSULE, GELATIN COATED 300 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-2527 CAPSULE, GELATIN COATED 300 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-2531 CAPSULE, GELATIN COATED 600 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-2531 CAPSULE, GELATIN COATED 600 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-4527 TABLET 300 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-4527 TABLET 300 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-8526 CAPSULE, GELATIN COATED 150 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-8526 CAPSULE, GELATIN COATED 150 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-8527 CAPSULE, GELATIN COATED 300 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-8527 CAPSULE, GELATIN COATED 300 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-8528 TABLET 300 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-8528 TABLET 300 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-8531 CAPSULE, GELATIN COATED 600 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0054-8531 CAPSULE, GELATIN COATED 600 mg ORAL NDA 26 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0378-1300 TABLET, FILM COATED, EXTENDED RELEASE 300 mg ORAL ANDA 17 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0378-1450 TABLET, EXTENDED RELEASE 450 mg ORAL ANDA 15 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0378-1450 TABLET, EXTENDED RELEASE 450 mg ORAL ANDA 15 sections
Lithium Carbonate HUMAN PRESCRIPTION DRUG LABEL 1 0615-8302 CAPSULE 300 mg ORAL ANDA 26 sections
LITHIUM CARBONATE HUMAN PRESCRIPTION DRUG LABEL 1 16590-781 TABLET 300 mg ORAL NDA 2 sections
Lithium carbonate HUMAN PRESCRIPTION DRUG LABEL 1 23155-763 TABLET, FILM COATED, EXTENDED RELEASE 300 mg ORAL ANDA 15 sections
Lithium carbonate HUMAN PRESCRIPTION DRUG LABEL 1 23155-763 TABLET, FILM COATED, EXTENDED RELEASE 300 mg ORAL ANDA 15 sections
lithium carbonate HUMAN PRESCRIPTION DRUG LABEL 1 31722-544 CAPSULE 150 mg ORAL ANDA 25 sections
lithium carbonate HUMAN PRESCRIPTION DRUG LABEL 1 31722-545 CAPSULE 300 mg ORAL ANDA 25 sections
lithium carbonate HUMAN PRESCRIPTION DRUG LABEL 1 31722-546 CAPSULE 600 mg ORAL ANDA 25 sections